Kim, Helena Kyunghee
Banik, Suman
Husain, Muhammad Ishrat
Tang, Victor
Levitan, Robert
Daskalakis, Zafiris J.
Kloiber, Stefan http://orcid.org/0000-0002-6838-4114
Funding for this research was provided by:
Temerty Faculty of Medicine, University of Toronto
Article History
Received: 2 February 2022
Accepted: 8 November 2022
First Online: 2 February 2023
Declarations
:
: Not applicable.
: Not applicable.
: SK reports grants from the Labatt Family Innovation Fund in Brain Health (Department of Psychiatry, University of Toronto), the Max Bell Foundation, the Canadian Centre on Substance Use and Addiction, the Ontario Ministry of Health and Long-Term Care (MOHLTC), the Canadian Institutes of Health Research (CIHR). SK has received honorarium for past consultation for EmpowerPharm. SK and MIH are supported by the University of Toronto Department of Psychiatry Academic Scholar Award. MIH reports grants from CIHR, CAMH Foundation, Grand Challenges Canada, and University of Toronto. MIH has served as scientific advisor to Mindset Pharma, Psyched Therapeutics, and Wake Network. ZJD has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc and Magventure Inc. He is also on the scientific advisory board for Brainsway Inc and Gazebo Health Inc. His work has been supported by the National Institutes of Mental Health (NIMH), CIHR, Brain Canada and the Temerty Family, Grant and Kreutzcamp Family Foundations. HKK, SB, VT, and RL have no conflict of interest to disclose.